The pitch is seductive. One blood draw reads your body's chemistry, cholesterol particles, blood sugar, inflammation, hormones, organ function. One scan looks at your body's structure, head to thigh, for things that bloods can never see. Put them together and surely you catch everything early. The reality is more interesting, and more useful to understand before you spend the money. The science behind these two halves is not equally strong, and knowing where it's strong and where it's thin is the whole game.
The short version: the cheap half (the bloods, plus a heart calcium score) has the strongest evidence, and the expensive half (whole-body MRI in a healthy person) has the weakest. That is the opposite of how the market usually prices and sells these scans. Here is why.
Why combine them at all
Bloods and imaging answer different questions. Bloods tell you how your body is working right now: are your cholesterol-carrying particles high, is your blood sugar creeping up, is there hidden inflammation, are your kidneys and liver coping. Imaging tells you what your body looks like: is there a lump, a narrowing, a structural change a blood marker would never flag.
Used well, they're complementary. A blood panel can tell you that your heart-attack risk is high years before anything hurts; a scan can confirm whether that risk has already turned into something physical. The logic is sound. The catch is in the detail of which scan, for which person, and what you do with what it finds.
The case for: where the science is genuinely good
Some of these tests are among the best-evidenced things in preventive medicine. They're also, not coincidentally, the cheapest.
✓ What earns its place
- ApoB, Lp(a), hs-CRP, HbA1c. ApoB is now considered one of the strongest blood predictors of heart attack, and a better one than standard LDL cholesterol. From 2026, US guidelines recommend every adult measures Lp(a) at least once.
- A heart calcium score (CT). A score of zero reliably reassures; a high score reliably escalates. It's in the guidelines as a decision tool, with sub-millisievert radiation.
- A clean whole-body MRI is genuinely reassuring. Reported false-negative rates are very low (around 0.2% in the largest provider's own data), so a normal scan does mean something.
- No radiation from the MRI. Unlike CT, an MRI uses magnets, not X-rays, so the scan itself carries no radiation dose.
! What to be careful about
- Incidental findings are the norm, not the exception. Around 95% of healthy adults have at least one finding on whole-body MRI, and roughly 9 in 10 of those don't matter clinically.
- The false-alarm cascade. In one large study, of people who went on to biopsy after a scan finding, about 6 in 10 had no cancer. That's worry, cost and procedures for nothing.
- Low cancer yield, uncertain benefit. Scans find cancer in only 1 to 2% of healthy people, and there's no trial proof that whole-body screening of average-risk people helps them live longer.
- Major radiology bodies don't endorse it for routine use in people without symptoms or high genetic risk.
The value of the combination comes mostly from the £200 of testing, not the £2,000 scan. That's worth knowing before you book.
The case against: the incidentaloma problem
This is the single most important thing to understand, because it's the downside nobody selling you a scan leads with. When you image the whole body of a healthy person at high resolution, you find things. Lots of things. Most are harmless: a benign cyst on a kidney, a small spot on the liver, a thyroid nodule, a lesion that's been there your whole life and will never cause harm.
The problem isn't the finding itself, it's what happens next. A finding you can't immediately dismiss leads to a follow-up test. Sometimes that's another scan, occasionally with radiation. Sometimes it's a biopsy, with a small but real risk of complications. And often, at the end of the chain, the answer is "it was nothing." You've paid in money, time, and genuine anxiety, for reassurance you could arguably have had without ever looking.
There's also overdiagnosis: finding a real but harmless cancer that would never have grown enough to hurt you, and then treating it anyway, with all the side effects of treatment and none of the benefit. Because there's no randomised trial showing whole-body MRI screening helps average-risk people live longer, we can't yet separate the cancers worth finding from the ones that were never going to matter.
How the modalities stack up
A blunt summary of the evidence behind each piece. Strong means guideline-backed and outcome-linked; weak means real but unproven for routine screening.
| Test | Evidence | Best for |
|---|---|---|
| ApoB / Lp(a) / hs-CRP / HbA1c (bloods) | Strong | Almost everyone. Cheap, repeatable, changes what a doctor does. |
| Heart calcium score (CT) | Strong | Settling cardiac risk in the 40+ "should I act?" group. |
| DEXA (bone density) | Strong, in the right group | Post-menopausal, older, or higher-fracture-risk people. |
| Whole-body MRI (average-risk person) | Weak for screening | Baseline-curious people who accept the false-alarm trade-off. |
| Whole-body MRI (high genetic risk) | Reasonable | Hereditary cancer syndromes, where guidelines do support it. |
| Cancer-detection blood tests (MCED) | Unproven on outcomes | Still experimental. The largest trial missed its main target. |
So, who is it actually worth it for?
This isn't a yes or no. It depends entirely on who you are.
Likely worth it
If you're over 40 and want to know your true cardiovascular risk, the bloods plus a calcium score are high-value and low-harm. If you have a strong family history or a known genetic risk of a particular cancer, targeted imaging (sometimes whole-body MRI) is genuinely indicated. If you've had specific symptoms or an abnormal blood result, a scan aimed at that question is appropriate and useful.
Probably not worth it
If you're a healthy, average-risk person in your 30s with no symptoms, a blanket whole-body MRI "to be safe" is where the evidence is weakest and the false-alarm risk is highest. You're statistically far more likely to end up chasing a harmless finding than to have your life saved. The bloods, by contrast, are still worth doing, they're cheap and they actually change decisions.
The honest verdict
Combining bloods and imaging is a good idea, done in the right order, for the right person. Start with the cheap, high-yield, decision-changing tests: a proper blood panel, and a calcium score if heart risk is the question. Add imaging when a result, a symptom, or your genetics actually points to it.
Reach for a whole-body MRI as a blanket annual scan and you've bought the most expensive, least-proven part first, and signed up for a roughly 9-in-10 chance that anything it finds won't matter. That can still be a reasonable personal choice, as long as you go in knowing the trade-off rather than the marketing.
The right test is the one matched to your risk and your question, not the one with the biggest machine.
Not sure what you actually need?
Tell Max your age, history and what's on your mind. We'll start with the tests that genuinely change decisions, and only suggest imaging where the evidence backs it.
Ask Max what's right for meSources
- Canadian Association of Radiologists. Policy statement: whole-body MRI screening in asymptomatic individuals (2025).
- O'Sullivan et al. Potentially serious incidental findings on whole-body MRI: systematic review and meta-analysis.
- Fred Hutch. Whole-body MRI and cancer screening (2025).
- Fortune. The full-body MRI: benefits and drawbacks.
- Frontiers in Radiology. Coronary artery calcium scoring in 2026.
- HCPLive. Lp(a) and ApoB in the 2026 dyslipidaemia guidelines.
- Drug Discovery News. What the NHS-Galleri trial really tells us about MCED.
This guide is general information, not medical advice or a diagnosis. Screening decisions are personal and should be made with a doctor who knows your history. If you have urgent symptoms, contact 999 or 111. Imaging is delivered through our imaging partners; blood analysis is performed by a UKAS-accredited laboratory.